Legal Representation
Attorney
Richard Y. Kim
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 11, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 11, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 10, 2008 | EX3G | S | EXTENSION 3 GRANTED | Loading... |
| Oct 10, 2008 | EXT3 | S | EXTENSION 3 FILED | Loading... |
| Oct 10, 2008 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
| Apr 8, 2008 | EX2G | S | EXTENSION 2 GRANTED | Loading... |
| Apr 8, 2008 | EXT2 | S | EXTENSION 2 FILED | Loading... |
| Apr 8, 2008 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
| Oct 9, 2007 | EX1G | S | EXTENSION 1 GRANTED | Loading... |
| Oct 9, 2007 | EXT1 | S | EXTENSION 1 FILED | Loading... |
| Oct 9, 2007 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
| Apr 10, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 16, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 27, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Nov 29, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Nov 27, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 9, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 8, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 27, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 27, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 12, 2006 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Oct 12, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 11, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 11, 2006 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | Loading... |
Detailed Classifications
Class 005
Eye drops; pharmaceutical eye drop formulations used for the treatment of inflammation and pain in the eye; and pharmaceutical preparations and substances for use in the prevention or treatment of diseases of the eye
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005